Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-30 @ 2:10 PM
Study NCT ID:
NCT01146535
Status:
COMPLETED
Last Update Posted:
2013-08-21
First Post:
2010-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
Sponsor:
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-16
First Submit QC Date:
None
Study First Post Date:
2010-06-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-19
Last Update Post Date:
2013-08-21
Last Update Post Date Type:
ESTIMATED